213 related articles for article (PubMed ID: 16215384)
1. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.
Suzuki T; Morisaki H; Serita R; Yamamoto M; Kotake Y; Ishizaka A; Takeda J
Crit Care Med; 2005 Oct; 33(10):2294-301. PubMed ID: 16215384
[TBL] [Abstract][Full Text] [Related]
2. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
[TBL] [Abstract][Full Text] [Related]
3. Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
Wang Z; Wu Q; Nie X; Guo J; Yang C
J Surg Res; 2016 Jan; 200(1):283-9. PubMed ID: 26316443
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockade during sepsis: inspired or insane?
Meldrum DR
Crit Care Med; 2005 Oct; 33(10):2433-4. PubMed ID: 16215413
[No Abstract] [Full Text] [Related]
5. Beta-1 blocker improves survival of septic rats through preservation of gut barrier function.
Mori K; Morisaki H; Yajima S; Suzuki T; Ishikawa A; Nakamura N; Innami Y; Takeda J
Intensive Care Med; 2011 Nov; 37(11):1849-56. PubMed ID: 21847651
[TBL] [Abstract][Full Text] [Related]
6. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Wang Z; Wu Q; Nie X; Guo J; Yang C
Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
[TBL] [Abstract][Full Text] [Related]
8. Esmolol attenuates lung injury and inflammation in severe acute pancreatitis rats.
Zhang L; Nie Y; Zheng Y; Ke L; Tong Z; Li W; Li J
Pancreatology; 2016; 16(5):726-32. PubMed ID: 27269252
[TBL] [Abstract][Full Text] [Related]
9. Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.
Huang MH; Wu Y; Nguyen V; Rastogi S; McConnell BK; Wijaya C; Uretsky BF; Poh KK; Tan HC; Fujise K
Cardiovasc Drugs Ther; 2011 Jun; 25(3):223-32. PubMed ID: 21562974
[TBL] [Abstract][Full Text] [Related]
10. Esmolol Administration to Control Tachycardia in an Ovine Model of Peritonitis.
Hosokawa K; Su F; Taccone FS; Post EH; Pereira AJ; Herpain A; Creteur J; Vincent JL
Anesth Analg; 2017 Dec; 125(6):1952-1959. PubMed ID: 28708664
[TBL] [Abstract][Full Text] [Related]
11. Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection.
Lu Y; Yang Y; He X; Dong S; Wang W; Wang D; Zhang P
Am J Emerg Med; 2017 Oct; 35(10):1480-1484. PubMed ID: 28457762
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
Du W; Wang XT; Long Y; Liu DW
Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452
[TBL] [Abstract][Full Text] [Related]
13. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
[TBL] [Abstract][Full Text] [Related]
14. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
[TBL] [Abstract][Full Text] [Related]
15. Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients.
Suttner S; Boldt J; Mengistu A; Lang K; Mayer J
Br J Anaesth; 2009 May; 102(5):597-607. PubMed ID: 19336536
[TBL] [Abstract][Full Text] [Related]
16. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.
Aboab J; Sebille V; Jourdain M; Mangalaboyi J; Gharbi M; Mansart A; Annane D
Intensive Care Med; 2011 Aug; 37(8):1344-51. PubMed ID: 21567116
[TBL] [Abstract][Full Text] [Related]
17. Left Ventricle Function During Therapeutic Hypothermia with Beta
Bergan HA; Halvorsen PS; Espinoza A; Kerans V; Skulstad H; Fosse E; Bugge JF
Ther Hypothermia Temp Manag; 2018 Sep; 8(3):156-164. PubMed ID: 29394143
[TBL] [Abstract][Full Text] [Related]
18. The effects of esmolol and dexmedetomidine on myocardial oxygen consumption during sympathetic stimulation in dogs.
Willigers HM; Prinzen FW; Roekaerts PM
J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):364-70. PubMed ID: 16750737
[TBL] [Abstract][Full Text] [Related]
19. Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
Boselli E; Jacquet-Lagrèze M; Ayoub JY; Bouvet L; Dauwalder O; Mansour C; Margez T; Paquet C; Restagno D; Allaouchiche B; Bonnet-Garin JM; Junot S
J Vet Emerg Crit Care (San Antonio); 2018 Sep; 28(5):447-456. PubMed ID: 30074662
[TBL] [Abstract][Full Text] [Related]
20. [Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients].
Chen JX; Sun J; Liu YY; Jia BH
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1243-6. PubMed ID: 23902616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
